Company profile: Anterios
1.1 - Company Overview
Company description
- Provider of botulinum-based prescription products for aesthetic medicine and dermatology and nanotechnology-based delivery systems for administering drugs and cosmetics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Anterios
Farcast Biosciences
HQ: United States
Website
- Description: Provider of a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Farcast Biosciences company profile →
Phenocell
HQ: France
Website
- Description: Provider of iPSC-derived cell models and R&D outsourcing for pharmaceutical, drug discovery, ophthalmology, dermatology, and dermo-cosmetic applications, including retinal pigment epithelial cells for retinal disorder research, a Dry AMD drug discovery platform, sebocytes for acne/hyperseborrhea, melanocytes for pigmentation, and high-throughput screening and custom bioassays with high genomic stability and reproducibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenocell company profile →
Ncardia
HQ: The Netherlands
Website
- Description: Provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ncardia company profile →
Ossiform
HQ: Denmark
Website
- Description: Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossiform company profile →
Lipofabrik
HQ: France
Website
- Description: Provider of biological and biodegradable molecules produced through bioprocesses based on renewable resources, including lipopeptides such as Fengycin, Plipastatin, Iturin, Lichenysin, Mycosubtilin, and Surfactin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lipofabrik company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Anterios
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Anterios
2.2 - Growth funds investing in similar companies to Anterios
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Anterios
4.2 - Public trading comparable groups for Anterios
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →